Lockheed Martin's Dividend Streak Faces Fixed-Price Contract Risk

What happened

Lockheed Martin has raised its dividend for 23 straight years, supported by a single dominant customer, but recent quarters have exposed the vulnerability of that cash cushion when fixed-price contracts go wrong. The company's Q2 2026 results showed strong missile demand, with record backlog of $230.4 billion driven by a $35 billion THAAD contract and growing PAC-3 orders, yet Aeronautics continues to absorb unfavorable profit adjustments, including $125 million on F-16 and $95 million on C-130. While cash flow rebounded in Q2 after a weak Q1, the lumpiness underscores that dividend coverage is not immune to execution missteps on legacy fixed-price programs. The stock at $582.6 trades at 21.4x forward earnings and 19.5x EV/EBITDA, already pricing in much of the missile upside without fully discounting the risk of further charges. Management's pause on share buybacks to fund the Ultra Maritime Solutions acquisition and working capital needs shows capital allocation is tightening even as the dividend continues.

Implication

The dividend streak is likely to continue, but the margin of safety is thin given execution risks on fixed-price contracts. Long-term holders can maintain positions, but new money should be patient; the thesis hinges on missile backlog broadening beyond THAAD and MFC margins sustaining above 14% while Aeronautics stabilizes. A break below $545 would offer a more attractive risk/reward, while confirmation of clean execution could justify a higher entry.

Thesis delta

The new article adds no material information beyond what was already reflected in the latest filings and DeepValue report, so the investment thesis remains unchanged: WAIT. The fixed-price contract risk cited by the article is already a key negative in the report's bear case, and no new data alters the probability of that scenario. The thesis continues to depend on funded PAC-3 awards and no further charges.